Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neurotrophic peptides for the treatment of tauopathies

Neurotrophic peptides for the treatment of tauopathies

US Patent 9327011 · Granted May 3, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of tauopathies with mGluR5 antagonists2019
Treatment of tauopathies by passive immunization targeting the N-terminal projec2019
Treatment of tauopathies by passive immunization targeting the N-terminal projec2019
Neurogenic brain-derived neurotrophic factor peptides2018
Neurogenic brain-derived neurotrophic factor peptides2018
Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide 2017
Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide 2017
Neurogenic brain-derived neurotrophic factor peptides2016
Neurogenic brain-derived neurotrophic factor peptides2016
Treatment of brain injury with a neurotrophic peptide2016
Treatment of brain injury with a neurotrophic peptide2016
Neurotrophic peptides2014